Vir Biotechnology Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio6.5310.37
Forward P/E18.86
P/S Ratio13.6215.702.085.0044.67
P/B Ratio0.880.851.623.834.76
Price/Tangible Book0.900.871.663.975.12
Price/FCF2.11
Price/OCF2.03
Enterprise Value Ratios
EV/Revenue2.820.714.2134.06
EV/EBITDA1.3710.81
EV/EBIT1.3910.96
EV/FCF0.72
Profitability & Returns
Return on Equity (ROE)-0.38%-0.34%0.29%0.49%-0.52%
Return on Assets (ROA)-0.20%-0.17%0.22%0.18%-0.26%
Return on Invested Capital (ROIC)-1.96%1.71%0.89%-6.51%
Return on Capital Employed (ROCE)-0.41%-0.38%0.36%0.26%-0.36%
Leverage & Solvency Ratios
Debt/Equity0.090.080.060.100.10
Debt/EBITDA0.150.31
Debt/FCF0.08
Liquidity Ratios
Current Ratio8.719.054.934.587.80
Quick Ratio7.618.744.764.347.46
Efficiency Ratios
Asset Turnover0.040.040.680.760.11
Yield & Distribution Ratios
Earnings Yield-0.52%-0.45%0.15%0.10%-0.09%
FCF Yield-0.45%-0.59%0.47%-0.01%-0.06%
Buyback Yield-0.02%0.01%-0.01%-0.12%-2.93%